Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Viking Therapeutics
ISIN US92686J1060
|WKN A12GD6
Market cap (in EUR)
3,067 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 3,067 m |
| EPS, EUR | -1.92 |
| P/B ratio | 5.0 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | - |
| Net income, EUR | -102 m |
| Profit margin | - |
What ETF is Viking Therapeutics in?
There are 3 ETFs which contain Viking Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Viking Therapeutics is the JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist).
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% | Equity World Social/Environmental | 495 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.01% | Equity North America Social/Environmental | 27 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.07% | Equity United States Small Cap | 182 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.